Professional Summary

Professional Overview

Robin Kramer is the Executive Vice President and Chief Financial Officer at Biogen, a leading biotechnology company. With over 30 years of experience in finance and accounting, Kramer brings a wealth of expertise in driving strategic financial initiatives and overseeing complex financial operations within highly regulated industries.

Experience Summary

Current Role

As the Executive Vice President and Chief Financial Officer at Biogen, Kramer is responsible for overseeing the company's financial strategy, reporting, and control functions. She plays a crucial role in ensuring the company's financial integrity and supporting its growth initiatives. Kramer also serves as the Chair of the Board of Directors and Audit Committee Chair at Armata Pharmaceuticals, Inc., where she provides strategic financial guidance and governance oversight.

Career Progression

Prior to her current role, Kramer held senior finance and accounting positions at various leading organizations. She served as the Senior Vice President and Chief Accounting Officer at Hertz, where she spearheaded the company's financial transformation initiatives. Kramer also held partner roles at renowned accounting firms such as Deloitte & Touche LLP, E&Y, and Arthur Andersen, where she advised clients on complex accounting and financial reporting matters.

Kramer's diverse background and leadership experience have enabled her to drive positive change and contribute to the success of the organizations she has been a part of.

Academic Background

Kramer holds a Bachelor's degree in Accounting from a leading university. She is a Certified Public Accountant (CPA) and has maintained her professional certifications throughout her career.

Areas of Expertise

• Financial strategy and planning

• Regulatory compliance and financial reporting

• Mergers, acquisitions, and integration

• Operational optimization and cost management

• Corporate governance and audit oversight

• Leadership and team development

Professional Impact

Kramer has demonstrated a track record of driving impactful financial initiatives and contributing to the growth and success of the organizations she has been associated with. She has been recognized for her ability to navigate complex financial and regulatory environments, while also fostering strong partnerships and leading high-performing teams.

Conclusion

With her extensive experience, strong financial acumen, and proven leadership abilities, Robin Kramer is a highly respected finance executive capable of navigating the evolving challenges facing the biotechnology industry. In her current role at Biogen and her board positions, Kramer continues to make valuable contributions to the organizations she serves, demonstrating her commitment to driving financial excellence and creating long-term value.